Actinium Pharmaceuticals Inc ATNM:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
9.73quote price arrow down-0.07 (-0.71%)
Volume
1,991,515
Close
9.80quote price arrow down-0.05 (-0.51%)
Volume
203,837
52 week range
4.00 - 10.24
Loading...
  • Open9.84
  • Day High9.95
  • Day Low9.46
  • Prev Close9.85
  • 52 Week High10.24
  • 52 Week High Date05/14/24
  • 52 Week Low4.00
  • 52 Week Low Date11/28/23

Key Stats

  • Market Cap291.878M
  • Shares Out29.78M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change92.91

KEY STATS

  • Open9.84
  • Day High9.95
  • Day Low9.46
  • Prev Close9.85
  • 52 Week High10.24
  • 52 Week High Date05/14/24
  • 52 Week Low4.00
  • 52 Week Low Date11/28/23
  • Market Cap291.878M
  • Shares Out29.78M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change92.91

RATIOS/PROFITABILITY

  • EPS (TTM)-1.72
  • P/E (TTM)-5.70
  • Fwd P/E (NTM)-5.50
  • EBITDA (TTM)-49.109M
  • ROE (TTM)-91.92%
  • Revenue (TTM)81,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-57,346.91%
  • Debt To Equity (MRQ)0.06%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Actinium Pharmaceuticals Inc

 

Profile

MORE
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for...
Sandesh Seth
Chairman of the Board, Chief Executive Officer
Steve O'Loughlin
Chief Financial Officer
Address
100 Park Ave., 23Rd Floor
New York, NY
10017
United States

Top Peers

SYMBOLLASTCHG%CHG
DSGN
Design Therapeutics Inc
4.41-0.09-2.00%
IPSC
Century Therapeutics Inc
3.01-0.12-3.83%
IVVD
Invivyd Inc
2.40-0.05-2.04%
ACRV
Acrivon Therapeutics Inc
8.89+0.33+3.86%
CADL
Candel Therapeutics Inc
11.50-1.20-9.45%